Tiefenbacher Group celebrating new buildings in Hyderabad
Exciting News from Tiefenbacher Group! We are thrilled to announce the grand inauguration of our newly constructed development and production facilities in Hyderabad, India! This marks…
Tiefenbacher Pharmaceuticals Launch: Varenicline in UK
Tiefenbacher Pharmaceuticals successfully prepares the launch of Varenicline in the United Kingdom We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be…
Tiefenbacher Group finalizing renovation
We are thrilled to announce the completion of the Tiefenbacher Group renovation of our office at the Port of Hamburg.The finalization of the 4th floor marks a significant milestone, ensuring that our…
Tiefenbacher Group wishes you a happy new year!
As 2024 draws to a close, the Tiefenbacher Group wishes you a Happy New Year and likes to share some of the year's highlights with you. This year we celebrated many significantly…
Tiefenbacher Laboratories Celebrating End-of-Year Fest
Last week, Tiefenbacher Laboratories hosted its much-anticipated End-of-Year Party at our R&D and manufacturing site in India.This annual fest brought together our dedicated employees from…
Tiefenbacher Group employees together for a good cause
We are delighted to inform you that a significant part of our Tiefenbacher Group employees has once again raised a substantial amount for a good cause this year.On behalf of the beneficiary…
Tiefenbacher Group Christmas Party 2024
Last week, our team came together to celebrate the Tiefenbacher Group Christmas Party in style at the stunning Restaurant am Kai in Hamburg.It was an evening filled with delicious food, delightful…
Celebrating World Children’s Day at Tiefenbacher Group
Every year on November 20th, the world comes together to celebrate World Childrens Day, a day dedicated to raising awareness about children’s rights and welfare.This special date marks the adoption…
Tiefenbacher Group celebrating World Diabetes Day
Diabetes and well-being is the theme for World Diabetes Day 2024-26.On November 14th, we join the global community in recognizing World Diabetes Day, a day dedicated to raising awareness about the…
Tiefenbacher Group Mental Health Day
Prioritizing Mental Health in a Busy WorldIn honor of World Mental Health Day this October, Tiefenbacher Group organized a “Mental Health Awareness Day” for all our employees at AET…
Tiefenbacher Group employee benefits
The Tiefenbacher Group employee benefits programme in Hamburg offers a wide range of options for back care and prevention of back pain.As a 100% family-owned leading healthcare company, we care about…
Tiefenbacher Group celebrating Delorbis 10th Birthday
Tiefenbacher Group celebrating a Decade of Excellence:Tiefenbacher Group is delighted to announce a significant milestone in the journey of Delorbis Pharmaceuticals Ltd, our state-of-the-art…
Tiefenbacher Group CPHI Milan 2024
Tiefenbacher Group reflecting on incredible days at CPHI in Milan!We had the pleasure of engaging in many inspiring conversations over the course of the three days, reconnecting with…
Tiefenbacher Laboratories supports victims of Rahat floods
Tiefenbacher Laboratories employees in India actively participated in Goonj’s material collection drives to support the victims of the Rahat floods.Tiefenbacher Group’s Hyderabad facility is a key…
Pioneering Healthcare at Tiefenbacher Group
Curiosity Driven, Excellence Focused, Patient CenteredAt Tiefenbacher Group, we believe that our expertise must be leveraged for the greater good – to improve patients’ lives worldwide by pioneering…
Tiefenbacher Group Celebrating World Pharmacists Day
On this World Pharmacists Day, we at Tiefenbacher Group join the global community in celebrating the theme “Pharmacists: Meeting global health needs”.This day, organized by the International…
Tiefenbacher Pharmaceuticals New Market Launch: Ezetimibe/Atorvastatin
Tiefenbacher Pharmaceuticals successfully prepares the launch of the generic version of Ezetimibe/Atorvastatin across the European Union We at Tiefenbacher Pharmaceuticals strongly believe that our…
Tiefenbacher Group International Night 2024
Tiefenbacher Group celebrates 3rd International NightWe are thrilled to look back on our 3rd International Night, an annual tradition that celebrates all international employees who have joined the…
Tiefenbacher Group Earns EcoVadis Silver Medal!
Exciting News: Tiefenbacher Group Earns EcoVadis Silver Medal!We are thrilled to announce that Tiefenbacher Group has been awarded the EcoVadis Silver Medal, highlighting our strong commitment to…
Tiefenbacher First to Market Launch: Varenicline in Europe
Tiefenbacher Pharmaceuticals successfully prepares the launch of Varenicline in the European Union We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be…
Tiefenbacher Laboratories Blood Donation Camp
Tiefenbacher Laboratories celebrates "International Humanitarian Day" with a blood donation campToday we are celebrating “International Humanitarian Day” with a blood donation camp on our…
Pioneering Healthcare at Tiefenbacher Group
Curiosity Driven, Excellence Focused, Patient CenteredAt Tiefenbacher Group, we believe that our expertise must be leveraged for the greater good – to improve patients’ lives worldwide by pioneering…
Tiefenbacher Group Employee Self-Care Day
Employee Self-Care Day at Tiefenbacher Group, Hyderabad, IndiaWe’re thrilled to announce the successful conclusion of our Employee Self-Care Day! Our team in Hyderabad came together for an…
Tiefenbacher Group partnering with Pharmacists Without Borders
Today we are very pleased to announce that Tiefenbacher Group is expanding the support for Pharmacists Without Borders, a non-profit organization that is close to our hearts and our pharmaceutical…
Tiefenbacher Group Pilates & Yoga
At Tiefenbacher Group, we start the day with Yoga and PilatesAt Tiefenbacher Group, we attach great importance to the well-being and health of our employees. That’s why we offer two free Yoga…
Tiefenbacher Group Social Day 2024
Tiefenbacher Group Employees Give Back to the CommunityOn the Tiefenbacher Group Social Day 2024, our employees once again took an active role in supporting the local community by volunteering with…
New laboratory and production site for Oncology medicines
Did you know that Tiefenbacher Group is in the final phase of constructing a new, state-of-the-art laboratory and production site for highly potent drugs against cancer and other…
Tiefenbacher Group celebrating US Independence Day
Today is one of the most important public holidays in the United States of America, celebrating its freedom. At the 4th July 1776, by the adoption of the Declaration of Independence, it declared its…
Tiefenbacher Group “Bike to work days”
This month, some of our valued Tiefenbacher Group colleagues took part in the "Bike to Work Days". A total of 786 journeys to work were made by bike and an incredible 15,000 kilometers were…
Tiefenbacher Group Luncheon in Hyderabad
It is a tradition at Tiefenbacher Group that our new employees can take part in an open table talk and luncheon with the leadership team, this time in Hyderabad.This involves an open discussion about…
Tiefenbacher Group Football Cup 2024
Just in time for the start of the UEFA Euro 2024 kick off in Germany, the Tiefenbacher Group in Hamburg organized its annual football tournament.This year, more than 200 people (employees and their…
Tiefenbacher Group draws attention to blood donation
On today's World Blood Donor Day, Tiefenbacher Group would like to actively support the Red Cross blood donation services and draw attention to blood donation and its importance for society with the…
Tiefenbacher New Market Launch: Buprenorphine in Australia
Tiefenbacher Pharmaceuticals successfully prepared the launch of the analgesic Buprenorphine as Transdermal Patch in Australia.We at Tiefenbacher Pharmaceuticals strongly believe that our…
Tiefenbacher New Market Launch: Bilastine as Oral Dispersible Tablet (ODT)
Tiefenbacher Pharmaceuticals successfully prepared the launch of the antihistamine Bilastine as Oral Dispersible Tablet (ODT) medicine in GermanyAs the allergy season is in full swing, we at…
Tiefenbacher Group celebrates The International Day of Families
Today we celebrate The International Day of Families!We would like to use the International Day of Families to talk about our Tiefenbacher Group family. Since 1963 Tiefenbacher Group…
TIEFENBACHER API + INGREDIENTS offers custom synthesis of intermediates & APIs
Synthesis of Active Pharmaceutical Ingredients (API) : From route scouting to lab scale development to commercial supply Did you know that Tiefenbacher API + Ingredients not only…
Tiefenbacher Group renovation of headquarters in Hamburg
Tiefenbacher Group is keeping you updated on the ongoing renovation of our headquarters at the Port of Hamburg in Germany.This month we reopened our 3rd floor and we are happy to present you some of…
Tiefenbacher Group invites young people to Girls’ & Boys’ Day
Tiefenbacher Group invited some of our employees' children in Hamburg to spend a day with us at our headquarters to mark Germany's Future Day for young people.The Girls’ & Boys’ Day…
Tiefenbacher Group celebrates Earth Day 2024
We are pleased to inform you that TIEFENBACHER GROUP is successfully on its way to becoming climate neutral by the end of 2025*.Every year, Earth Day provides the keynote for a wide range of…
Tiefenbacher first-to-market launch: Rivaroxaban
Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban. We at Tiefenbacher Group strongly believe that our high-quality medicines should be affordable and…
Tiefenbacher Group welcomes new COO Sandip Tarate
We are pleased to welcome our new COO for AET Laboratories, Sandip Tarate, to Tiefenbacher Group.Sandip has joined our site in Hyderabad, India, with 23+ years of extensive experience in the…
Tiefenbacher Group raises awareness of autism
Tiefenbacher Group raises awareness of autism on today's World Autism Awareness Day.Obviously the aim of World Autism Awareness Day is to draw attention to the needs and lifelong…
Tiefenbacher Group greetings from DCAT Week!
Today is the last day of one of the world´s most important pharma events – DCATWeek in New York City!Our Tiefenbacher Group team sends greetings and their impressions of DCAT Week from…
Tiefenbacher Group awarded EcoVadis silver medal!
We are excited to share that Tiefenbacher API + Ingredients has been awarded the EcoVadis Silver Medal!EcoVadis is the world’s largest provider of business sustainability ratings. The EcoVadis…
Tiefenbacher Group celebrates International Women’s Day
Today Tiefenbacher Group celebrates International Women's Day, that's why we would like to introduce you to two valuable female employees from our company.Get to know the women who are working at…
Tiefenbacher Group on awareness for rare disease day
Tiefenbacher Group draws attention to Rare Disease Day.Today we are focusing on awareness and generating change for the 300 million people worldwide living with rare diseases. Treatment for many rare…
Tiefenbacher Group supports Pharmacists in Ukraine
Tiefenbacher Group supporting people in Ukraine by donating to Pharmacists without borders.The 24 February 2024, marks the second anniversary of the brutal Russian war against a sovereign Ukraine.…
Tiefenbacher Group renovation of headquarters
Tiefenbacher Group keeping you updated on the ongoing renovation of our headquarters at the Port of Hamburg in Germany.Tiefenbacher Group is happy to present some of the results of the remodelling…
Tiefenbacher API + Ingredients wishes a Happy Chinese New Year!
The Chinese New Year is almost here.On the 10th of February, people around the world celebrate the Chinese New Year. They honour this day with carnival events, family gatherings, parades, traditional…
Tiefenbacher API+ Ingredients together against blood cancer
Tiefenbacher API+ Ingredients and DKMS together against blood cancerDKMS Group is an international nonprofit organization dedicated to the fight against blood cancer and blood disorders by creating…
Tiefenbacher API+ Ingredients speaks out against racism and supports diversity
Tiefenbacher API+ Ingredients speaks out against racism and supports diversity – as a healthcare company, we are committed to stopping racism and discrimination, wherever we can.Tiefenbacher…
Tiefenbacher API + Ingredients wishes you a happy new year!
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP: As 2023 draws to a close, we would like to share some of the year's highlights with you. This year we not only had our…
TIEFENBACHER API + INGREDIENTS at CPhI Barcelona 2023
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP: three days at CPHI 2023 in Barcelona
TIEFENBACHER API + INGREDIENTS: 60 years anniversary celebrations at Tiefenbacher Group
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP: 60th anniversary this year! Pioneering Healthcare since 1963 We are very happy to announce that Tiefenbacher Group…
TIEFENBACHER GROUP sustainable impact in Hyderabad/India
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP: relocation of trees in Hyderabad – contribution to our India community to make life better for people and planetAt Tiefenbacher Group, we…
TIEFENBACHER API + INGREDIENTS: Raw Materials for Animal Health
TIEFENBACHER API + INGREDIENTS offers Raw Material for Animal Health: Companion and Farm AnimalsDid you know that Tiefenbacher API + Ingredients offers in addition to its extensive…
Approval of manufacturing and laboratory facilities by Saudi Food and Drug Authority (SFDA)
Tiefenbacher: Own manufacturing and laboratory facilities successfully registered by the Saudi Food and Drug Authority (SFDA) for GCC regionThe SFDA approves Tiefenbacher facilities! We are happy to…
TIEFENBACHER GROUP is committed to becoming climate neutral
Tiefenbacher Group is committed to becoming climate neutral by the end of 2025 – sustainability contribution to make life better for people and planetWe are pleased to share that TIEFENBACHER GROUP…
TIEFENBACHER: Renovation Headquarters in Hamburg /Germany
Tiefenbacher Group: Renovating Headquarters in Hamburg: novel ways of working in an agile, open-plan work space Tiefenbacher Group is renovating the Headquarters in Hamburg for flexible…
TIEFENBACHER GROUP AT DCAT 2023 – THANKS FOR MEETING US IN NEW YORK CITY!
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP DCAT week 2023 – one of the world´s most important pharma events – has just come to an end. It was four very successful and…
TIEFENBACHER API + INGREDIENTS WISHES A HEALTHY NEW YEAR 2023
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP: Happy New Year 2023 From all over the world, we wish you a happy and healthy New Year 2023!Tiefenbacher Group wishes a…
Thanks for visiting us at CPhI 2022 in Frankfurt!
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP: Three successful days at CPhI 2022 – Thank you for visiting us in Frankfurt! CPhI 2022, the world`s leading pharma event,…
TIEFENBACHER GROUP opens new manufacturing site in Cyprus
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP: new manufacturing site in Cyprus for drug production Did you know that TIEFENBACHER GROUP heavily invests in its in-house…
Meet TIEFENBACHER API + INGREDIENTS at CPhI 2022 in Frankfurt
Meet TIEFENBACHER API + INGREDIENTS at CPhI in Frankfurt from 1-3 Nov and discover to secure the pharmaceutical industry with high-quality APIWe are very excited to meet our valued customers and…
TIEFENBACHER API + INGREDIENTS: Employee benefits and climate reduction goals
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP: Environmentally friendly and health-promoting – we offer bike leasing to employeesEmployees benefits while reducing our impact on the…
TIEFENBACHER GROUP becomes member of the Pharmaceutical Supply Chain Initiative (PSCI)
TIEFENBACHER GROUP becomes member of the Pharmaceutical Supply Chain Initiative (PSCI) – contribution to sustainable and responsible businessWe at TIEFENBACHER GROUP are committed to promote…
TIEFENBACHER GROUP OPENS NEW SITE FOR HIGHLY POTENT DRUGS IN INDIA
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP:New site for highly potent drugs in IndiaTIEFENBACHER GROUP is excited to announce the ceremonious opening of our new highly potent drug…
WORLD HEALTH DAY @ TIEFENBACHER API + INGREDIENTS
World Health Day is on the 7th of April each year – this day marks the anniversary of the Word Health Organization (WHO)Today we celebrate World Health Day. This Day marks the anniversay of the World…
TIEFENBACHER GROUP AT DCAT 2022 – THANKS FOR MEETING US IN NEW YORK CITY!
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP: Thanks for meeting us at DCAT 2022 in New York One of the world´s most important pharma events – DCAT-Week in New York City…
TIEFENBACHER API + INGREDIENTS stands with Ukraine
Peace and freedom for Ukraine: We, a API-distributor in Europe, stand in solidarity with the people in UkraineTo us at TIEFENBACHER API + INGREDIENTS, it is unbearable to witness what is happening in…
MEET TIEFENBACHER GROUP DURING DCAT WEEK IN NEW YORK CITY 2022
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUPReach out to TIEFENBACHER GROUP at DCAT in New York City from 21-24th March and discover our latest ideas to make pharmaceuticals more…
TIEFENBACHER GROUP WISHES A HAPPY AND HEALTHY NEW YEAR 2022 FROM ALL OVER THE WORLD!
We at TIEFENBACHER GROUP wish you a happy and healthy new year 2022 from all over the world! Please watch the short video for our new year greetings from our colleagues from our three…
Three successful days for TIEFENBACHER GROUP at CPhI 2021 – thanks for visiting us in Milano!
TIEFENBACHER API + INGREDIENTS at CPHI 2021 With over 1,300 exhibitors and more than 20,000 attendees the world`s leading pharma event CPhI has just come to an end. It was three very…
TIEFENBACHER GROUP: New school building in India
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP:Giving back to society is important to us – New school building in India As a value-driven healthcare company, dedicated to…
Reach out to TIEFENBACHER API + INGREDIENTS at CPhI 2021 in Milan
TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP: Reach out to us at CPhI 2021 in Milan and discover our latest ideast product portfolio and innovations“Nothing can replace meeting each…
TIEFENBACHER API + INGREDIENTS: Controlled Substance
TIEFENBACHER API + INGREDIENTS secures the supply of controlled substances for customers and patientsWe at TIEFENBACHER API + INGREDIENTS assure patients have a better access to controlled substance…
TIEFENBACHER API + INGREDIENTS: Pitavastatine Calcium for novel therapies
TIEFENBACHER API + INGREDIENTS offers Pitavastatine Calcium for novel therapiesWe at TIEFENBACHER API + INGREDIENTS help to bridge the gap between drug development and market access by providing…
TIEFENBACHER API offers first API based on green chemistry: Enviero Progesterone
TIEFENBACHER API + INGREDIENTS starts to offer the first API based on green chemistry: Enviero ProgesteroneWe at TIEFENBACHER API + INGREDIENTS are committed to drive green chemistry in the…
TIEFENBACHER API + INGREDIENTS: GMP certificated Natural Medicinal Cannabidiol (CBD)
TIEFENBACHER API + INGREDIENTS offer GMP certificated Natural Medicinal Cannabidiol (CBD) with highest purity profile in the marketWe bring pharma-quality standards of cannabis API for the benefit…
TIEFENBACHER API + INGREDIENTS: Dexmedetomidine Hydrochloride – COVID-19 Patients
TIEFENBACHER API + INGREDIENTS secures the supply of critical drug for COVID-19 Patients: Dexmedetomidine HydrochlorideWe ensure hospitals have access to the medicines needed for patient care,…
TIEFENBACHER API + INGREDIENTS: New website – Pioneering API-Distribution since 1963
New Website for TIEFENBACHER PHARMACEUTICALS + INGRIDIENTS: Full-service distributor for high-quality APIs (Human + Vet) + controlled substances with value-added services.“We are very thrilled to…
Tiefenbacher Group and OnDosis enter a strategic partnership for medicines and digital health
Tiefenbacher Group and OnDosis enter a strategic partnership for game-changing integration of medicines and digital healthTiefenbacher Group and OnDosis today announced the signing of an extensive…
